Angiotensin-II-derived reactive oxygen species on baroreflex sensitivity during hypertension: New perspectives

Frontiers in Physiology

Volumn 4 MAY, Issue , 2013, Pages

  de Queiroz, Thyago M ^a   Monteiro, Matheus M O ^a   Braga, Valdir A ^a  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

Angiotensin II; Antioxidants; Baroreflex; Hypertension; NADPH oxidase

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; APOCYNIN; ASCORBIC ACID; ATROPINE; MELATONIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TEMPOL; TIRON;

ARTICLE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEART RATE; HUMAN; HYPERTENSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PRESSORECEPTOR REFLEX; PROTEIN EXPRESSION; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; VASODILATATION;

EID: 84883791484     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00105     Document Type: Article

References (78)

1. Allen, A. M., Dosanjh, J. K., Erac, M., Dassanayake, S., Hannan, R. D., and Thomas, W. G. (2006). Expression of constitutively active angiotensin receptors in the rostral ventrolateral medulla increases blood pressure. Hypertension 47, 1054-1061.
2. Allen, A. M., Moeller, I., Jenkins, T. A., Zhuo, J., Aldred, G. P., Chai, S. Y., et al. (1998). Angiotensin receptors in the nervous system. Brain Res. Bull. 47, 17-28.
3. Babior, B. M. (2004). NADPH oxidase. Curr. Opin. Immunol. 16, 42-47.
4. Botelho-Ono, M. S., Pina, H. V., Sousa, K. H. F., Nunes, F. C., Medeiros, I. A., and Braga, V. A. (2011). Acute superoxide scavenging restores depressed baroreflex sensitivity in renovascular hypertensive rats. Auton. Neurosci. 159, 38-44.
5. Braga, V. A. (2010). Dietary salt enhances angiotensin-II-induced superoxide formation in the rostral ventrolateral medulla. Auton. Neurosci. 155, 14-18.
6. Braga, V. A. (2011). Differential brain angiotensin-II type I receptor expression in hypertensive rats. J. Vet. Sci. 12, 291-293.
7. Braga, V. A., Burmeister, M. A., Zhou, Y., Sharma, R. V., and Davisson, R. L. (2008). Selective ablation of AT1a receptors in rostral ventrolateral medulla (RVLM) prevents chronic angiotensin-II-dependent hypertension in part by reducing oxidant stress in this region. Hypertension 52, 36.
8. Braga, V. A., Colombari, E., and Jovita, M. G. (2011a). Angiotensin II-derived reactive oxygen species underpinning the pro-cessing of the cardiovascular reflexes in the medulla oblongata. Neurosci. Bull. 27, 269-274.
9. Braga, V. A., Medeiros, I. A., Ribeiro, T. P., França-Silva, M. S., Botelho-Ono, M. S., and Guimarães, D. D. (2011b). Angiotensin-II-derived reactive oxygen species along the SFO-PVN-RVLM pathway: implications in neurogenic hypertension. Braz. J. Med. Biol. Res. 44, 814-965.
10. Burmeister, M. A., Young, C. N., Braga, V. A., Butler, S. D., Sharma, R. V., and Davisson, R. L. (2011). In vivo bioluminescence imaging reveal redox-regulated activator protein-1 activation in paraventricular nucleus of mice with renovascular hypertension. Hypertension 57, 289-297.
11. Cai, H., and Harrison, D. G. (2000). Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87, 840-844.
12. Campagnole-Santos, M. J., Diz, D. I., Santos, R. A., Khosla, M. C., Brosnihan, K. B., and Ferrario, C. M. (1989). Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats. Am. J. Physiol. Heart. Circ. Physiol. 257, 324-329.
13. Campos, R. R. (2009). Oxidative stress in the brain and arterial hypertension. Hypertens. Res. 32, 1047-1048.
14. Campos, R. R., Oliveira-Sales, E. B., Nish, E. M., Boim, M. A., Dolnikoff, M. S., and Bergamaschi, C. S. (2011). The role of oxidative stress in renovascular hypertension special series: stress and hypertension. Clin. Exp. Pharmacol. Physiol. 38, 144-152.
15. Chabrashvili, T., Tojo, A., Onozato, M. L., Kitiyakara, C., Quinn, M. T., Fujita, T., et al. (2002). Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39, 269-274.
16. Chang, S. Y., Chen, Y. W., Chenier, I., Tran Sle, M., and Zhang, S. L. (2011). Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2. Exp. Diabetes Res. 2011:521076. doi: 10.1155/2011/521076
17. Chen, X., Touyz, R. M., Park, J. B., and Schiffrin, E. L. (2001). Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38, 606-611.
18. Costa, C. A., Amaral, T. A., Carvalho, L. C., Ognibene, D. T., da Silva, A. F., Moss, M. B., et al. (2009). Antioxidant treatment with tempol and apocynin prevents endothelial dysfunction and development of renovascular hypertension. Am. J. Hypertens. 22, 1242-1249.
19. Chrissobolis, S., Banfi, B., Sobey, C. G., and Faraci, F. M. (2012). Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain. J. Appl. Physiol. 113, 184-191.
20. Dampney, R. A., Tan, P. S., Sheriff, M. J., Fontes, M. A., and Horiuchi, J. (2007). Cardiovascular effects of angiotensin II in the rostral ventrolateral medulla: the push-pull hypothesis. Curr. Hypertens. Rep. 9, 222-227.
21. Davisson, R. L., and Zimmerman, M. C. (2010). Angiotensin, II, oxidant signaling, and hypertension: down to a T? Hypertension 55, 228-230.
22. de Champlain, J., Wu, R., Girouard, H., Karas, M., Midaoui, A. E., Laplante, M. A., et al. (2004). Oxidative stress in hypertension. Clin. Exp. Hypertens. 8, 593-601.
23. Duffy, S. J., Gokce, N., Holbrook, M., Huang, M., Frei, B., keaney, J. F., et al. (1999). Treatment of hypertension with ascorbic acid. Lancet 354, 2048-2049.
24. Ferrario, C. M., Trask, A. J., and Jessup, J. A. (2005). Advances in the biochemical and functional roles of angiotensin converting enzyme 2 and angiotensin- (1-7) in the regulation of cardiovascular function. Am. J. Physiol. Heart. Circ. Physiol. 289, 2281-2290.
25. Girouard, H., Denault, C., Chulak, C., and Champlain, J. (2004). Treatment by N-acetylcysteine and melatonin increases cardiac baroreflex and improves antioxidant reserve. Am. J. Hypertens. 17, 947-954.
26. Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., and Alexander, R. W. (1994). Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74, 1141-1148.
27. Griendling, K. K., Murphy, T. J., and Alexander, R. W. (1993). Molecular biology of the renin-angiotensin system. Circulation 87, 1816-1828.
28. Guimarães, D. D., Carvalho, C. C., and Braga, V. A. (2012). Scavenging of NADPH oxidase-derived superoxide anions improves depressed baroreflex sensitivity in spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 39, 373-378.
29. Herrera, M., and Garvin, J. L. (2010). Angiotensin II stimulates thick ascending limb NO production via AT(2) receptors and Akt1-dependent nitric-oxide synthase 3 (NOS3) activation. J. Biol. Chem. 285, 14932-14940.
30. Higashi, Y., Sasaki, S., Nakagawa, K., Matsuura, H., Oshima, T., and Chayama, K. (2002). Endothelial function and oxidative stress in renovascular hypertension. N. Engl. J. Med. 346, 1954-1962.
31. Horiuchi, M., Hayashida, W., Akishita, M., Tamura, K., Daviet, L., Lehtonen, J. Y. A., et al. (1999). Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk. Circ. Res. 84, 876-882.
32. Houston, M. C. (2005). Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension. Prog. Cardiovasc. Dis. 47, 396-449.
33. Ichikawa, I., and Brenner, B. M. (1980). Importance of efferent arteriolar vascular tone in regulation of proximal tubule fluid reabsorption and glomerulotubular balance in the rat. J. Clin. Invest. 65, 1192-1201.
34. Ichiki, T., Miyazaki, R., Kamiharaguchi, A., Hashimoto, T., Matsuura, H., Kitamoto, S., et al. (2012). Resveratrol attenuates angiotensin II-induced senescence of vascular smooth muscle cells. Regul. Pept. 177, 35-39.
35. Infanger, D. W., Sharma, R. V., and Davisson, R. L. (2006). NADPH oxidases of the brain: distribution, regulation, and function. Antioxid. Redox Signal. 8, 1583-1596.
36. Ito, M., Oliverio, M. I., Mannon, P. J., Best, C. F., Maeda, N., Smithies, O., et al. (1995). Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc. Natl. Acad. Sci. U.S.A. 92, 3521-3525.
37. Ito, S., Komatsu, K., Tsukamoto, K., Kanmatsuse, K., and Sved, A. F. (2002). Ventrolateral medulla AT1 receptors support blood pressure in hypertensive rats. Hypertension 40, 552-559.
38. Kishi, T., and Hirooka, Y. (2013). Oxidative stress in the brain causes hypertension via sympathoexcitation. Front. Physiol. 3:335. doi: 10.3389/fphys.2012.00335
39. Kishi, T., Hirooka, Y., Kimura, Y., Ito, K., Shimokawa, H., and Takeshita, A. (2004). Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 109, 2357-2362.
40. Kitiyakara, C., and Wilcox, C. S. (1998). Antioxidants for hypertension. Curr. Opin. Nephrol. Hypertens. 7, 531-538.
41. Landmesser, U., Dikalov, S., Price, S. R., Mc-Cann, L., Fukai, T., Holland, S. M., et al. (2003). Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Investig. 111, 1201-1209.
42. Laplante, M. A., Wu, R., El Midaoui, A., and De Champlain, J. (2003). NAD(P)H oxidase activation by angiotensin II is dependent on p 42 / 44 ERK-MAPK pathway activation in rats vascular smooth muscle cells. J. Hypertens. 21, 927-936.
43. Laursen, J. B., Rajagopalan, S., Galis, Z., Tarpey, M., Freeman, B. A., and Harrison, D. G. (1997). Role of superoxide in angiotensin II-induced but not catecholamine induced hypertension. Circulation 95, 588-593.
44. Lefkowits, R. J., and Willerson, J. (2001). Prospects for cardiovascular research. JAMA 285, 581-587.
45. Li, J., Culman, J., Hortnagl, H., Zhao, Y., Gerova, N., Timm, M., et al. (2005). Angiotensin AT2 receptor protects against cerebral ischemia induced neuronal injury. FASEB J. 19, 617-619.
46. Lob, H. E., Marvar, P. J., Guzik, T. J., Sharma, S., McCann, L. A., Weyand, C., et al. (2010). Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension 55, 277-283.
47. Masilamani, S., Kim, G. H., Mitchell, C., Wade, J. B., and Knepper, M. A. (1999). Aldosterone-mediated regulation of ENaC α, β, and γ subunit proteins in rat kidney. J. Clin. Invest. 104, 19-23.
48. Monteiro, M. M. O., França-Silva, M. S., Alves, N. F. B., Porpino, S. K. P., and Braga, V. A. (2012). Quercetin improves baroreflex sensitivity in spontaneously hypertensive rats. Molecules 17, 12997-13008.
49. Navar, L. G., Carmines, P. K., Huang, W. C., and Mitchell, K. D. (1987). The tubular effects of angiotensin II. Kidney Int. Suppl. 20, 81-88.
50. Nishi, E. E., Oliveira-Sales, E. B., Bergamaschi, C. T., Oliveira, T. G., Boim, M. A., and Campos, R. R. (2010). Chronic antioxidant treatment improves arterial renovascular hypertension and oxidative stress markers in th e kidney in Wistar rats. Am. J. Hypertens. 23, 473-480.
51. Nishikawa, Y., Tatsumi, K., Matsura, T., Yamamoto, A., Nadamoto, T., and Urabe, K. (2003). Effects of vitamin C on high blood pressure induced by salt in spontaneously hypertensive rats. J. Nutr. Sci. Vitaminol. 49, 301-309.
52. Nunes, F. C., and Braga, V. A. (2011). Chronic angiotensin II infusion modulates angiotensin II type I receptor expression in the subfornical organ and the rostral ventrolateral medulla in hypertensive rats. J. Renin Angiotensin Aldosterone Syst. 12, 440-445.
53. Ogawa, K., Hirooka, Y., Shinohara, K., Kishi, T., and Sunagawa, K. (2012). Inhibition of oxidative stress in rostral ventrolateral medulla improves impaired baroreflex sensitivity in stroke-prone spontaneously hypertensive rats. Int. Heart. J. 53, 193-198.
54. Oliveira-Sales, E. B., Dugaich, A. P., and Abreu, N. P. (2008). Oxidative stress supports blood pressure and sympathetic activity in renovascular hypertension. Am. J. Hypertens. 21, 98-104.
55. Oliverio, M. I., Best, C. F., Kim, H. S., Arendshorst, W. J., Smithies, O., and Coffman, T. M. (1997). Angiotensin II responses in AT1A receptor-deficient mice: a role for AT1B receptors in blood pressure regulation. Am. J. Physiol. 272, 515-520.
56. Pacher, P., Beckman, J. S., and Liaudet, L. (2007). Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315-424.
57. Padia, S. H., and Carey, R. M. (2013). AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function. Pflugers Arch. 465, 99-110.
58. Paravicini, T. M., and Touyz, R. M. (2006). Redox signaling in hypertension. Cardiovasc. Res. 71, 247-258.
59. Peach, M. J. (1977). Renin-angiotensin system: biochemistry and mechanisms of action. Physiol. Rev. 57, 313-370.
60. Peterson, J. R., Burmeister, M. A., Tian, X., Zhou, Y., Guruju, M. R., Stupinski, J. A., et al. (2009). Genetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin, II. Hypertension 54, 1106-1114.
61. Prewitt, R. L., Dobrian, A. D., and Schriver, S. D. (2001). Role of Angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension. Hypertension 38, 361-366.
62. Queiroz, T. M., Guimarães, D. D., Mendes-Júnior, L. G., and Braga, V. A. (2012). α-Lipoic acid reduces hypertension and increases baroreflex sensitivity in renovascular hypertensive rats. Molecules 17, 13357-13367.
63. Queiroz, T. M., MacHado, N. T., Furtado, F. F., Oliveira-Filho, A. A., Alustau, M. C., Figueiredo, C. S., et al. (2011). Vasorelaxation induced by Dictyota pulchella (Dictyotaceae), a brown alga, is mediated via inhibition of calcium influx in rats. Mar. Drugs 9, 2075-2088.
64. Rajagopalan, S., Kurz, S., Munzel, T., Tarpey, M., Freeman, B. A., Griendling, K. K., et al. (1996). Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NAD(P)H oxidase activation: contribution to alterations of vasomotor tone. J. Clin. Investig. 97, 1916-1923.
65. Sadjadi, J., Puttaparthi, K., Welborn, M. B., Rogers, T. E., Moe, O., Clagett, G. P., et al. (2002). Upregulation of autocrineparacrine renin-angiotensin systems in chronic renovascular hypertension. J. Vasc. Surg. 36, 386-392.
66. Santos, R. A. S., Silva, A. C. S., Maric, C., Silva, D. M. R., MacHado, R. P., de Buhr, I., et al. (2003). Angiotensin-(1-7) is an endogenous ligand for the G protein coupled receptor Mas. Proc. Natl. Acad. Sci. U.S.A. 100, 8258-8263.
67. Stegbauer, J., and Coffman, T. M. (2011). New insights into angiotensin receptor actions: from blood pressure to aging. Curr. Opin. Nephrol. Hypertens. 20, 84-88.
68. Sun, C., Zubcevic, J., Polson, J. W., Potts, J. T., Diez-Freire, C., Zhang, Q., et al. (2009). Shift to an involvement of phosphatidylinositol 3-kinase in angiotensin II actions on nucleus tractus solitarii neurons of the spontaneously hypertensive rat. Circ. Res. 105, 1248-1255.
69. Touyz, R. M., Yao, G., and Schiffrin, E. L. (2003). c-Src induces phosphorylation and 533translocation of p47phox: role in superoxide generation by angiotensin II in human 534 vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 23, 981-987
70. Turko, I. V., and Murad, F. (2002). Protein nitration in cardiovascular diseases. Pharmacol. Rev. 54, 619-634.
71. Ungvari, Z., Csiszar, A., Kaminski, P. M., Wolin, M. S., and Koller, A. (2004). Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system. Am. J. Pathol. 165, 219-226.
72. Wolin, M. S. (2005). Loss of vascular regulation by soluble guanylate cyclase is emerging as a key target of the hypertensive disease process. Hypertension 45, 1068-1069.
73. Wu, L., and De Champlain, J. (1999). Effects of superoxide on signaling pathways in smooth muscle cells from rats. Hypertension 34, 1247-1253.
74. Xu, P., Sriramula, S., and Lazartigues, E. (2011). ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, 804-817.
75. Xue, B., Beltz, T. G., Johnson, R. F., Guo, F., Hay, M., and Johnson, A. K. (2012). PVN adenovirus-siRNA injections silencing either NOX2 or NOX4 attenuate aldosterone/NaCl-induced hypertension in mice. Am. J. Physiol. Heart Circ. Physiol. 302, H733-H741.
76. Zimmerman, M. C., Dunlay, R. P., Lazartigues, E., Zhang, Y., Sharama, R. V., Engelhardt, J. F., et al. (2004a). Requirement for Rac 1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ. Res. 95, 532-539.
77. Zimmerman, M. C., Lazartigues, E., Sharma, R. V., and Davisson, R. L. (2004b). Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ. Res. 95, 210-216.
78. Zimmerman, M. C., Lazartigues, E., Lang, J. A., Sinnayah, P., Ahmad, I. M., Spitz, D. R., et al. (2002). Superoxide mediates the actions of angiotensin II in the central nervous system. Circ. Res. 91, 1038-1045.